ChiCTR-IOR-17013259
正在进行
/
/
/
2017-11-03
/
/
Overweight/Obesity
Breaking up Prolonged Sitting with Light-intensity Walking and Sitting Bouts Duration on Postprandial Metabolic Responses in Overweight/Obese Male Adults
Breaking up Prolonged Sitting with Light-intensity Walking and Sitting Bouts Duration on Postprandial Metabolic Responses in Overweight/Obese Male Adults
Breaking up Prolonged Sitting with Light-intensity Walking and Sitting Bouts Duration on Postprandial Metabolic Responses in Overweight/Obese Male Adults
随机交叉对照
其它
Randomized
Single-blind for Trial subjects
No
/
25
/
1990-01-01
1990-01-01
/
1. Chinese men aged between 18 and 34 years; 2. With overweight/obesity (Body Mass Index is higher than 22.9 km/m^2); 3. Physically inactive (moderate-intensity physical activity is less than 150 minutes per week for the past 3 months); 4. Total time spent sitting is more than 5 hours per day; 5. Fluent in English.；
登录查看1. Allergic to milk or gluten; 2. With history of cardiovascular disease and/or diabetes; 3. Fasting blood glucose is over than 7 mmol/L, and/or 2-hour postprandial glucose in the 75-g Oral glucose tolerance test is over than 199 mg/dL, and/or HbA1C is over than 6.4%; 4. Smoker; 5. With conditions that alter limit capability to walk on a treadmill; 6. Taking any medications known to affect lipid or glucose metabolism; 7. Not fluent in English.；
登录查看香港中文大學教育學院
/
昌郁医药2024-11-22
上海和誉生物医药科技有限公司2024-11-22
云顶新耀2024-11-22
金斯瑞生物2024-11-22
细胞与基因治疗领域2024-11-22
肝脏时间2024-11-22
医药笔记2024-11-22
生物安全情报网2024-11-22
医药速览2024-11-22
亚盛医药2024-11-22
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
